Project Grant R21NS145048
Award Date 8/1/25
Completion Date 7/31/27
Dollars Obligated $251K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
- This $691,935 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders supports research to develop quantitative diffusion MRI methods for predicting neurodevelopmental outcomes in infants with hypoxic ischemic brain injury. The project aims to analyze diffusion MRI data from two large datasets - the High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL)...
- The federal Project Grant award of $884,573 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) is being used by Brigham & Women's Hospital Inc. to develop an "Abbreviated Yet Enhanced Neuro MRI Protocol." The project aims to reduce brain MRI exam duration by roughly three-fold while capturing quantitative and qualitative MRI contrasts as...
- This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $630,982 to The General Hospital Corporation (Massachusetts General Hospital) to conduct research on "Noninvasive Optical Assessment of Neuroprotection in Deep Hypothermic Circulatory Arrest Procedures". The award period runs from May 6, 2025 to February 28, 2030....
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $514,357 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to the Massachusetts Institute of Technology (MIT) on June 1, 2025. The purpose of this grant is to support the development and prototype demonstration of a portable, liquid-helium-free 1-T/560-mm RT bore point-of-care MRI magnet. This innovative MRI technology is intended to...
- This federal Project Grant award, valued at $492,749.00 and awarded by the National Institute of Neurological Disorders and Stroke (NINDS), supports the development of a novel non-invasive magnetic resonance imaging (MRI) technique called ratiometric dual contrast (RDUAL) pH-weighted MRI. The goal is to create an imaging tool that can accurately map the ischemic penumbra (tissue at risk of infarction) and evaluate the risk of reperfusion injury in acute ischemic stroke patients. This research,...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $147,486 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the Massachusetts Institute of Technology (MIT) from July 1, 2025 to June 30, 2027. The grant funds the development of a novel Magnetic Resonance Imaging (MRI) method to concurrently measure brain tissue displacement, blood dynamics, and cerebrospinal fluid (CSF) flow in humans. This research...
- This Project Grant award, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to significantly enhance quantitative magnetic resonance imaging (MRI) technology for in-vivo analysis of neurovascular structures and the early developing brain's response to perinatal stroke. The $511,583 award, with a project period from August 1, 2025 to May 31,...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $541,109 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of Washington. The 5-year grant, beginning January 1, 2025, will fund research to quantify myelin loss and recovery in ischemic stroke patients using a novel magnetic resonance imaging (MRI) technique called single-point macromolecular proton fraction (MPF) mapping. The...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides funding of $224,265 to the University of Pittsburgh to conduct research aimed at improving prognostication for patients with hypoxic-ischemic brain injury following sudden cardiac arrest. The project seeks to use principles of decision science and organizational behavior to develop and...
- This Project Grant award of $704,313 from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853, Extramural Research Programs in the Neurosciences and Neurological Disorders, aims to advance a prognostic and monitoring biomarker of neutrophil-driven secondary brain injury in spontaneous intracerebral hemorrhage. The primary objective is to define and validate a standardized protocol to detect specific neutrophil biomarker levels as a potential prognostic and...